Literature DB >> 12187253

Recurrent transitional cell carcinoma in a child with the Costello syndrome.

Shinji Urakami1, Mikio Igawa, Hiroaki Shiina, Kazushi Shigeno, Nobuyuki Kikuno, Tateki Yoshino.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12187253     DOI： 10.1097/01.ju.0000024188.20748.1c

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  10 in total

1.  Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases.

Authors:  B Kerr; M-A Delrue; S Sigaudy; R Perveen; M Marche; I Burgelin; M Stef; B Tang; O B Eden; J O'Sullivan; A De Sandre-Giovannoli; W Reardon; C Brewer; C Bennett; O Quarell; E M'Cann; D Donnai; F Stewart; R Hennekam; H Cavé; A Verloes; N Philip; D Lacombe; N Levy; B Arveiler; G Black
Journal:  J Med Genet       Date:  2006-01-27       Impact factor: 6.318

2.  Costello syndrome: Clinical phenotype, genotype, and management guidelines.

Authors:  Karen W Gripp; Lindsey A Morse; Marni Axelrad; Kathryn C Chatfield; Aaron Chidekel; William Dobyns; Daniel Doyle; Bronwyn Kerr; Angela E Lin; David D Schwartz; Barbara J Sibbles; Dawn Siegel; Suma P Shankar; David A Stevenson; Mihir M Thacker; K Nicole Weaver; Sue M White; Katherine A Rauen
Journal:  Am J Med Genet A       Date:  2019-06-20       Impact factor: 2.802

3.  Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.

Authors:  Lan Mo; Xiaoyong Zheng; Hong-Ying Huang; Ellen Shapiro; Herbert Lepor; Carlos Cordon-Cardo; Tung-Tien Sun; Xue-Ru Wu
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

4.  Immunotherapy With Bacillus Calmette-Guerin (BCG) in a 16-Year-Old With Urothelial Bladder Carcinoma.

Authors:  Jose M Martinez-Thomas; Luis F Galicia-Belaunzaran; Claudio E Merayo-Chalico; Joseph Palatchi; Juan Carlos Angulo-Lozano
Journal:  Cureus       Date:  2022-05-14

5.  Transitional cell carcinoma of the bladder in first decade of life.

Authors:  Ramnik Patel; Tim Tery; George K Ninan
Journal:  Pediatr Surg Int       Date:  2008-09-24       Impact factor: 1.827

6.  The impact of hospital volume, residency, and fellowship training on perioperative outcomes after radical prostatectomy.

Authors:  Quoc-Dien Trinh; Maxine Sun; Simon P Kim; Jesse Sammon; Keith J Kowalczyk; Ariella A Friedman; Shyam Sukumar; Praful Ravi; Fred Muhletaler; Piyush K Agarwal; Shahrokh F Shariat; Jim C Hu; Mani Menon; Pierre I Karakiewicz
Journal:  Urol Oncol       Date:  2013-03-01       Impact factor: 3.498

7.  Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic Targets.

Authors:  A Porrello; R B Piergentili
Journal:  Curr Genomics       Date:  2016-02       Impact factor: 2.236

8.  Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS.

Authors:  Christopher H Yee; Zongyu Zheng; Lauren Shuman; Hironobu Yamashita; Joshua I Warrick; Xue-Ru Wu; Jay D Raman; David J DeGraff
Journal:  Sci Rep       Date:  2019-01-22       Impact factor: 4.379

Review 9.  Biology of urothelial tumorigenesis: insights from genetically engineered mice.

Authors:  Xue-Ru Wu
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

Review 10.  Urothelial bladder tumour in childhood: A report of two cases and a review.

Authors:  Usama N Rifat; Nader Y Hamadalla; Khalid C Chiad Safi; Salwan S Al Habash; Mustafa Mohammed
Journal:  Arab J Urol       Date:  2014-11-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.